Organization | Centre pour le developpement des vaccines, Mali

Centre pour le developpement des vaccines, Mali Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial

2011

NCT01430689

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2017

Timeline

NOW

Now

Alternative names

Centre pour le Developpement des Vaccins - Mali

Active Ingredients

Drugs in Phase 4 Trials (3)

inactivated influenza vaccine (1 trial)

Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi) (1 trial)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)

Drugs in Phase 3 Trials (1)

azithromycin (zithromax) (1 trial)

Drugs in Phase 2 Trials (1)

cholera vaccine (Vaxchora) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Cholera (Phase 2)

Diarrhea (Phase 3)

Influenza, Human (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 3
# of Trial APIs: 5